Switzerland's Tecan to acquire medical device maker Paramit for USD1B

Over the current book year the total revenue from the company in Maennedorf will be 820.15 million CHF (consensus estimates). This is rather significant more than 2020's revenue of 730.88 million CHF.

Historical revenues and results Tecan plus estimates 2020

The analysts expect for 2021 a net profit of 122 million CHF. The majority of the analysts expects for this year a profit per share of 10.26 CHF. Based on this the price/earnings-ratio is 47.72.

Per share the analysts anticipate on a dividend of 2.61 CHF per share. Tecan 's dividend yield thus equals 0.53 percent. The average dividend yield of the health care companies equals a poor 1.46 percent.

Based on the current number of outstanding shares Tecan 's market capitalization is 5.81 billion CHF. The Tecan stock was the past 12 months quite volatile. Since last July the stock is even 34 percent higher. This year the stock price moved between 357 and 498 CHF.

Price data Tecan 2007-2021

At 10.18 the stock trades 0.78 percent lower at 489.6 CHF.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.